5-Oxo-2, 3,4,5-tetrahydro-benzo[b]oxepine-4-car boxylic acid amides and 2,3-Dihydro-benzo[b]oxepine-4-carboxy lic acid amides for treatment and prevention of Diabetes Typ 1 and 2

Details for Australian Patent Application No. 2009221339 (hide)

Owner Merck Patent GmbH

Inventors Burgdorf, Lars Thore; Emde, Ulrich; Beier, Norbert; Gleitz, Johannes; Saal, Christoph; Charon, Christine

Agent Davies Collison Cave

Pub. Number AU-A-2009221339

PCT Pub. Number WO2009/109270

Priority 08003856.5 01.03.08 EP

Filing date 5 February 2009

Wipo publication date 11 September 2009

International Classifications

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/109270 Priority application(s): WO2009/109270

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221343-Vertical-lift door assembly and lintel sealing unit therefor

2009221328-Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes